Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
NCT Number: NCT05232669
The COcoa Supplement and Multivitamin Outcomes Study (COSMOS; NCT02422745) is a randomized clinical trial of cocoa extract supplement (containing a total of 500 mg/d flavanols, including 80 mg. (-)-epicatechins), and a standard multivitamin supplement to reduce the risk of cardiovascular disease and cancer among men aged 60 years and older and women aged 65 years and older. This ancillary study is being conducted among participants in COSMOS and will examine whether the cocoa extract supplement or the multivitamin supplement improve musculoskeletal health and prevent falls and declining physical performance in the increasing number of older adults in the U.S. with potential for clinical and public health benefits.
This study is active but is not currently recruiting participants.
60 year and older
All sexes
Interventional
Not applicable
Boston, Massachusetts, 02115, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Participants in COSMOS (NCT02422745) who meet the following criteria are eligible to participate in this ancillary study:
2 capsules each day containing a total of 500 mg cocoa flavanols, including 80 mg (-)-epicatechin, and 50 mg theobromine
Cocoa extract placebo
Multivitamin
Multivitamin placebo
Time frame: 5 years
Time frame: 5 years
Brigham and Women's Hospital
Other
COcoa Supplement and Multivitamin Outcomes Study (COSMOS): Effects on Falls and Physical Performance
Acronym: COSMOS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04845269
Brain Diseases, Cardiovascular Diseases
Innsbruck, Austria
View Trial DetailsNCT04093856
Body Weight, Bone Diseases
Montreal, Quebec, Canada
View Trial DetailsNCT03409354
Brain Diseases, Bursitis
Singapore
View Trial DetailsNCT07199790
Balance Disorders, Behavior
Reus, Tarragona, Spain
View Trial Details